SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle is trending following strong earnings that beat analyst expectations, though the stock has faced downward pressure due to investor concerns over significant debt, ongoing cash-flow issues from heavy AI infrastructure spending, and a pre-scheduled share sale by Larry Ellison. While some traders view the pullback as manipulation or an opportunity to accumulate at a discount, others are wary of the company's financial position and the broader market's reaction to AI-related capital expenditure.

Innodata, Inc. is a data engineering company, which engages in providing artificial intelligence software platforms and management of its services. It operates through the following business segments: Digital Data Solutions (DDS), Synodex, and Agility. The DDS segment combines deep neural networks and human expertise in multiple domains to make unstructured information useable. The Synodex segment enables clients in the insurance and healthcare sectors to transform medical records into useable digital data and to apply technologies to the digital data to augment decision support. The Agility segment provides tools and related professional services that enable public relations and communications professionals to discover influencers, amplify messages, monitor coverage, and measure the impact of campaigns. The company was founded by Todd H. Solomon in 1988 and is headquartered in Ridgefield Park, NJ.

Innodata Inc

Innodata is facing downward price pressure driven by concerns over its share dilution via an ATM offering and high customer concentration risk, leading traders to anticipate a potential gap fill towards lower support levels. While some investors remain bullish on the long-term potential for agentic AI and M&A activity, technical analysis suggests a bearish trend as traders monitor for further selling and institutional accumulation at lower price points.

Sable Offshore Corp. engages in offshore oil and gas field operations. It focuses on developing the prolific Santa Ynez Unit in federal waters offshore California. The company was founded by James C. Flores on October 16, 2020 and is headquartered in Houston, TX.

Sable Offshore Corp.

Sable Offshore shares are trending as the company completes a major stock and note offering priced at $3.08, removing immediate liquidity concerns and allowing investors to focus on upcoming catalysts. Traders are closely monitoring the July 7th Ninth Circuit hearing and an expected ruling from Judge Wilson, which are viewed as critical steps to secure federal support for the company's Santa Ynez Pipeline restart.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklo shares are under pressure following the launch of a new $1 billion at-the-market equity offering program, fueling investor concerns regarding potential dilution. While some traders express frustration over the company's capital-raising strategy and insider share sales, others remain bullish on the long-term potential for nuclear energy to meet surging AI-driven data center power demand.

ERock, Inc. operates, designs, and installs distributed generation power systems. The firm primarily serves data centers, utilities, commercial and industrial businesses. The company was founded on 2006 and is headquartered in Houston, TX.

ERock Inc. - Ordinary Shares - Class A

Eagle Rock Energy Partners, L.P.

Eagle Rock is trending following its recent Anthropic deal and ongoing construction projects, with investors debating the company's long-term valuation as a provider of on-site microgrid power for AI data centers.

Lumen Technologies, Inc. is an investment holding company, which engages in the provision of integrated communications to residential and business customers. It operates through the Business and Mass Markets segments. The Business segment provides products and services under four sales channels to enterprise and commercial customers. The Mass Markets segment focuses on consumer and small business customers. The company was founded in 1930 and is headquartered in Monroe, LA.

Lumen Technologies Inc

Lumen Technologies is experiencing significant selling pressure amid concerns over its legacy business, heavy debt load, and the lack of immediate revenue inflection, leading investors to call for share buybacks and greater strategic clarity. While some remain bullish on the long-term AI networking opportunity, the stock has faced downward momentum following its removal from several Russell index benchmarks.

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Johnson & Johnson

Johnson & Johnson shares are trending following the announcement of a $5.5 billion proposed settlement to resolve the majority of pending talc-related ovarian cancer lawsuits. Investors are evaluating the settlement alongside the company's recent quarterly earnings beat, which featured raised full-year guidance despite some lingering concerns regarding its MedTech segment.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

The stock is experiencing a significant decline driven by retail panic and intense short-selling following the circulation of a third-party statistical model on social media that lowered the perceived probability of trial success. While some investors fear coordinated manipulation and potential downside, long-term shareholders maintain their bullish thesis, attributing the price action to algorithmic trading and a shakeout of weaker hands ahead of expected clinical trial results.

iShares Trust - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

The primary catalyst driving TLT is persistent bond market volatility tied to rising inflation fears and Treasury yields, exacerbated by ongoing Middle East tensions affecting energy prices. Traders are divided between anticipating a potential Federal Reserve rate hike and speculating on the efficacy of the Treasury's bond buyback programs in countering the broader selloff.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is trending as traders react to a Morgan Stanley downgrade to Underweight, which cited concerns over mid-term growth and potential patent expiration risks for its flagship drug, semaglutide. While some investors argue these risks are already priced into the stock and point to strong performance in the oral GLP-1 market as a sign of continued growth, others express frustration with the company's technical performance and management's guidance strategies.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
